374Water (SCWO) 10-Q 6 May 22 2022 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cover [Abstract]
Entity Registrant Name	374WATER INC.
Entity Central Index Key	0000933972
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	true
Entity Current Reporting Status	Yes
Document Period End Date	Mar. 31, 2022
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2022
Entity Ex Transition Period	false
Entity Common Stock Shares Outstanding		126,680,895
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-27866
Entity Incorporation State Country Code	DE
Entity Tax Identification Number	88-0271109
Entity Interactive Data Current	Yes
Entity Address Address Line 1	701 W Main Street
Entity Address Address Line 2	Suite 410
Entity Address City Or Town	Durham
Entity Address State Or Province	NC
Entity Address Postal Zip Code	27701
City Area Code	919
Local Phone Number	888-8194

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current Assets:
Cash	$ 11,243,795	$ 11,131,175
Prepaid Expenses	167,867	218,466
Total Current Assets	11,411,662	11,349,641
Long-term Assets:
Equipment, Net	4,015	959
Intangible Asset, Net	1,012,327	1,028,114
Other Assets	34,306	34,742
Total Long-term Assets	1,050,648	1,063,815
Total Assets	12,462,310	12,413,456
Current Liabilities:
Accounts Payable And Accrued Expenses	144,040	62,981
Deferred Revenue	763,333	0
Other Liabilities	3,152	23,390
Total Current Liabilities	910,525	86,371
Total Liabilities	910,525	86,371
Stockholders' Equity
Preferred Stock: 1,000,000 Convertible Series D Preferred Shares Authorized; Par Value $0.0001 Per Share, Nil Issued And Outstanding At March 31, 2022 And 27,272 Issued And Outstanding At December 31, 2021	0	3
Common Stock: 200,000,000 Common Shares Authorized, Par Value $0.0001 Per Share, 126,680,895 And 125,317,746 Shares Outstanding At March 31, 2022 And December 31, 2021, Respectively	12,669	12,531
Additional Paid-in Capital	15,571,989	15,474,566
Accumulated (deficit) Earnings	(4,032,873)	(3,160,015)
Total Stockholders' Equity	11,551,785	12,327,085
Total Liabilities And Stockholders' Equity	$ 12,462,310	$ 12,413,456

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2022	Dec. 31, 2021
Condensed Consolidated Balance Sheets
Preferred Stock, Shares Authorized	1,000,000	1,000,000
Preferred Stock Par Value	$ 0.0001	$ 0.0001
Preferred Stock, Shares Issued	0	27,272
Preferred Stock, Shares Outstanding	0	27,272
Common Stock, Shares Authorized	200,000,000	200,000,000
Common Stock, Par Value	$ 0.0001	$ 0.0001
Common Stock, Shares Issued	126,680,895	125,317,746
Common Stock, Shares Outstanding	126,680,895	125,317,746

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Condensed Consolidated Statements of Operations
Revenue	$ 273,231	$ 0
Cost Of Goods Sold	247,986	0
Gross Profit	25,245	0
Operating Expenses
Research And Development	185,653	29,185
Compensation And Related Expenses	301,235	18,686
Professional Fees	150,658	8,203
General And Administrative	261,403	10,477
Total Operating Expenses	898,950	66,551
Income (loss) From Operations	(873,705)	(66,551)
Other Income (expense)
Interest Income	840	0
Other Income	7	0
Total Other Income (expense)	847	0
Net Loss Before Income Taxes	(872,858)	(66,551)
Provision For Income Taxes	0	0
Net Loss	$ (872,858)	$ (66,551)
Net Loss Per Share - Basic And Diluted	$ (0.01)	$ 0
Weighted Average Common Shares Outstanding - Basic And Diluted	126,499,142	62,410,452

Condensed Consolidated Changes

Condensed Consolidated Changes in Stockholders' Deficit - USD ($)	Total	Preferred Stock	Common Stock [Member]	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)
Balance, Shares at Dec. 31, 2020			62,410,452
Balance, Amount at Dec. 31, 2020	$ 11,250	$ 0	$ 6,241	$ 416	$ 4,593
Accretion Of Stock-based Compensation	10,433	0	0	10,433	0
Net Loss	(66,551)	0	$ 0	0	(66,551)
Balance, Shares at Mar. 31, 2021			62,410,452
Balance, Amount at Mar. 31, 2021	(44,868)	$ 0	$ 6,241	10,849	(61,958)
Balance, Shares at Dec. 31, 2021		27,272	125,317,746
Balance, Amount at Dec. 31, 2021	12,327,085	$ 3	$ 12,531	15,474,566	(3,160,015)
Accretion Of Stock-based Compensation	97,558	0	0	97,558	0
Net Loss	$ (872,858)	$ 0	$ 0	0	(872,858)
Conversion Of Preferred Shares To Common Shares, Shares	1,363,149	(27,272)	1,363,149
Conversion Of Preferred Shares To Common Shares, Amount	$ 0	$ 3	$ 136	135	0
Balance, Shares at Mar. 31, 2022			126,680,895
Balance, Amount at Mar. 31, 2022	$ 11,551,785	$ 0	$ 12,667	$ 15,571,989	$ (3,884,460)

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash Flows From Operating Activities
Net Income (loss)	$ (872,858)	$ (66,551)
Adjustments To Reconcile Net Income (loss) To Net Cash Provided By (used In) Operating Activities:
Depreciation And Amortization Expense	16,458	0
Stock-based Compensation	97,558	10,433
Changes In Operating Assets And Liabilities
Accounts Receivable	0	24,340
Accounts Payable And Accrued Expenses	81,059	28,966
Deferred Revenue	763,333	0
Prepaid Expense	50,599	0
Other Liabilities	(20,238)	(1,200)
Cash Provided By (used In) Operating Activities	115,911	(4,022)
Cash Flows From Investing Activities
Purchase Of Equipment	(3,291)	0
Cash Provided By (used In) Investing Activities	(3,291)	0
Cash Flows From Financing Activities
Funding From Exercise Of Capital Stock	0	4,821
Cash Provided By Financing Activities	0	4,821
Net Increase In Cash	112,620	799
Cash - Beginning Of The Period	11,131,175	71,799
Cash - End Of The Period	11,243,795	72,598
Non-cash Financing Activities:
Conversion Of Preferred Stock To Common Stock	$ 133	$ 0

Nature of Business and Presenta

Nature of Business and Presentation of Financial Statements	3 Months Ended
	Mar. 31, 2022
Nature of Business and Presentation of Financial Statements
Nature Of Business And Presentation Of Financial Statements	Note 1 – Nature of Business and Presentation of Financial Statements Description of the Company 374Water, Inc., f/k/a PowerVerde, Inc. (the “Company”) was a Delaware corporation formed in March 2007. The Company was formed to develop, commercialize, and market a series of unique electric generating power systems designed to produce electrical power with zero emissions or waste byproducts, based on a patented pressure-driven expander motor and related organic rankine cycle technology. On April 16, 2021, 374Water Inc. (f/k/a PowerVerde, Inc.) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with 374Water, Inc., a privately held company based in Durham, North Carolina, (“Private 374Water”) and 374Water Acquisition Corp., a newly-formed wholly-owned subsidiary of PowerVerde (“Sub”). The parties entered into the Agreement pursuant to their Binding Letter of Intent dated September 20, 2020. Pursuant to the merger contemplated by the Merger Agreement (the “Merger”), on April 16, 2021, Sub merged into Private 374Water, with Private 374Water as the surviving corporation. In connection with the Merger, all Private 374Water shares were cancelled and the Company issued to the former Private 374Water shareholders a total of 62,410,452 shares of the Company common stock. Immediately following the Merger, Private 374Water changed its name to 374Water Systems Inc and PowerVerde changed its name to 374Water, Inc. After the Merger, the former Private 374Water stockholders own 64.2% of the Company’s issued and outstanding common stock and 53.8% of the Company’s issued and outstanding voting stock which includes the Preferred Stock. The Merger was accounted for as a reverse acquisition (See Note 4). On April 16, 2021, as a result of the closing of the Merger Agreement (see Note 4), the equity of the consolidated entity is the historical equity of 374Water, Inc (“374Water”) retroactively restated to reflect the number of shares issued by the Company in the reverse recapitalization. Nature of Business With the Merger, the Company’s current mission is to support a clean and healthy environment to sustain life. The Company plans to use what it believes to be cutting-edge science to recover resources from the waste our society generates and keep drinking water clean. The Company’s customers will include businesses and local governments that will make the sustainable development goals a reality. On February 1, 2022, the Company sold their first AIRSCWO system to Orange County Sanitation District of Fountain Valley, California. Revenues to date have been from sale of the first AIRSCWO system and from testing, consulting, and advisory services procedures for our customers, which have been performed in collaboration with Duke University. Presentation of Financial Statements The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission (SEC) for interim financial information. It is management’s opinion that that the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q and include all adjustments (consisting only of normal recurring accruals) which are necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Annual Report on Form 10-K of 374Water Inc, formerly known as PowerVerde, Inc. (“374 Water," “we,” “us,” “our,” or the “Company”) as of and for the year ended December 31, 2021 filed with the Securities and Exchange Commission (“SEC”) on March 1, 2022. The results of operations for the three months ended March 31, 2022, are not necessarily indicative of the results to be expected for the full year or for future periods. The condensed consolidated financial statements include the accounts of 374Water Inc, formerly known as PowerVerde, Inc. (the “Company”), and PowerVerde Systems, Inc., 374Water Systems Inc, and 374Water Sustainability Israel LTD, each a wholly-owned subsidiary of 374 Water. Intercompany balances and transactions have been eliminated in consolidation. These interim financial statements reflect the acquisition of the Company’s new wholly-owned subsidiary, 374Water Systems Inc., which was consummated on April 16, 2021, as more fully disclosed in Note 4.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2022
Summary of Significant Accounting Policies
Summary Of Significant Accounting Policies	Note 2 – Summary of Significant Accounting Policies Cash and Cash Equivalents The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company held no cash equivalents as of March 31, 2022, and December 31, 2021. Accounts Receivable Accounts receivables consist of balances due from service revenues. The Company monitors accounts receivable and provides allowances when considered necessary. At March 31, 2022 and December 31, 2021, there were no outstanding accounts receivable. Accordingly, no allowance for doubtful accounts was provided. Equipment Equipment is recorded at cost. Depreciation is computed using the straight-line method and an estimated useful live of three years. Expenses for maintenance and repairs are charged to expense as incurred. The Company’s depreciation expense in the period is $235. Intangible Assets Intangible assets are subject to amortization, and any impairment is determined in accordance with ASC 360, “Property, Plant, and Equipment.” Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. Long-Lived Assets The Company reviews long-lived assets, including intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. Recoverability of assets held and used is measured by a comparison of the carrying amount to the future undiscounted expected net cash flows to be generated by the asset. As of March 31, 2022, and 2021, there were no events or changes in circumstances requiring an impairment analysis. Revenue Recognition and Concentration The Company follows the revenue standards of Financial Accounting Standards Board Update No. 2014-09: “Revenue from Contracts with Customers (Topic 606).” The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation. Deferred revenue primarily consists of billings or payments received in advance of revenue recognition from the completion of the equipment build for each customer as the outputs are measured against the cost to build the product. The Company’s performance obligations will be satisfied overtime as the specialized equipment is built for the customer. Based on the Company’s contracts, the Company will have a single performance obligation (build and install of the product). The Company will primarily receive fixed consideration for sales of product. Revenues for the three months ended March 31, 2022 were generated from the sale of the first AIRSCWO system. For the three months ended March 31, 2021, the Company did not have any revenues. Stock-based Compensation The Company has accounted for stock-based compensation under the provisions of Accounting Standards Codification (ASC) Topic 718 – “Stock Compensation” which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term. Accounting for Uncertainty in Income Taxes The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. There were no uncertain tax positions as of March 31, 2022, and December 31, 2021. Income Tax Policy The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date. Research and Development Costs The Company’s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $185,653 and $29,185 for the three months ended March 31, 2022, and 2021, respectively. Earnings (Loss) Per Share Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, “Earnings per Share”. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. As of March 31, 2022, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 12,660,000 shares of common stock. There were no dilutive shares as of March 31, 2022. Financial Instruments The Company carries cash, accounts receivable, accounts payable and accrued expenses, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values / useful lives of equipment and intangible assets due to their current nature. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, useful lives of intangible assets, and valuation allowance against deferred tax assets. Recent Accounting Pronouncements All other newly issued but not yet effective accounting pronouncements have been deemed to be not applicable or immaterial to the Company.

Liquidity Capital Resources and

Liquidity Capital Resources and Going Concern	3 Months Ended
	Mar. 31, 2022
Nature of Business and Presentation of Financial Statements
Liquidity, Capital Resources	Note 3 – Liquidity, Capital Resources and Going Concern As of March 31, 2022, the Company had working capital of $10,501,137 compared to working capital of $11,263,270 at December 31, 2021. As of March 31, 2022, the Company has an accumulated deficit of $4032873. For the three months ended March 31, 2022, the Company had a net loss of (872,858) and $115,911 of net cash provided by operations for the period. The Company believes they have sufficient cash-on-hand for the Company to meet its financial obligations for at least the next 12 months from the date of the report as they come due.

Acquisition of 374Water Inc fka

Acquisition of 374Water Inc fka PowerVerde Inc	3 Months Ended
	Mar. 31, 2022
Acquisition of 374Water Inc fka PowerVerde Inc
Acquisition Of 374water, Inc. F/k/a Powerverde Inc.	Note 4 – Acquisition of 374Water, Inc. f/k/a PowerVerde Inc. Agreement and Plan of Merger In connection with the Merger, (see Note 1), the Company closed on a private placement of 436,783 shares of Series D Convertible Preferred Stock (the “Preferred Stock”) with a par value of $0.0001, yielding gross proceeds of $6,551,745 (the “Private Placement”) and the settlement of a $50,000 liability for Preferred Stock shares. The Private Placement proceeds will be used for working capital, primarily for development, manufacture and commercialization of the Company’s Air SCWO systems. The Preferred Stock has a stated value of $15 per share, is convertible into common stock at $.30 per share and has voting rights based on the underlying shares of common stock. Upon liquidation of the Company, the Preferred Stockholders have liquidation preference before any assets can be distributed to common stockholders. All of the Preferred Stock was sold pursuant to an exemption from registration requirements under Regulation D and/or Section 4(2) of the Securities Act of 1933, as amended. As a result of the Merger, the issuance of the Preferred Stock, the former Private 374Water shareholders own 65.8% of the Company’s issued and outstanding common stock and 53.8% of the Company’s issued and outstanding voting stock (which includes the Preferred Stock on an as converted basis). Also as a result of the Merger, the Company entered into two-year employment agreements with the Company founders Yaacov (Kobe) Nagar and Marc Deshusses, Ph. D. Mr. Nagar will serve as the Company’s CEO, replacing Richard H. Davis, who resigned as CEO upon closing of the Merger. Mr. Nagar initially receive an annual salary of $200,000 which was increased to $250,000 effective January 26, 2022. Dr. Deshusses will serve as the Company’s Head of Technology on a part-time basis at a salary of $60,000 per year. Pursuant to the Merger, Messrs. Nagar and Deshusses were appointed to the Company’s Board of Directors, joining Mr. Davis, who remains as a Director. The patented technology underlying 374Water’s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (“Duke”), where Dr. Deshusses is a professor, is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the “License Agreement”) simultaneous with the merger. In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small block of shares of common stock (see Note 5). As a result of the Merger Agreement, for financial statement reporting purposes, the business combination between 374Water Inc. and 374Water was treated as a reverse acquisition and recapitalization for accounting purposes with 374Water deemed the accounting acquirer and 374Water Inc. deemed the accounting acquiree under the acquisition method of accounting in accordance with FASB Accounting Standards Codification (“ASC”) Section 805-10-55. The following assets and liabilities were assumed in the transaction: Cash $ 29,536 Prepaid expense 14,483 Accounts Receivable 1,000 Total assets acquired 45,019 Accounts payable (46,150 ) Accrued expenses (83,094 ) Total liabilities assumed $ (129,244 ) Net liabilities assumed $ (84,225 )

Intangible Assets

Intangible Assets	3 Months Ended
	Mar. 31, 2022
Intangible Assets
Intangible Assets	Note 5 – Intangible Assets Intangible assets are recorded at cost and consist of the license agreement with Duke University. The Company issued Duke University a small block of shares of common stock estimated to have a fair value of $1,073,529 as consideration for granting the Company the license based on the Company’s common stock market price on the date the license agreement was executed (see Note 8). Intangible assets are comprised of the following as of March 31, 2022 and December 31, 2021: Name Estimated Life Balance at December 31, 2021 Additions Amortization Balance at March 31, 2022 License agreement 17 Years $ 1,028,114 $ — $ 15,787 $ 1,012,327 Patents 20 Years 34,742 — 436 34,306 Total $ 1,062,856 $ — $ 16,223 $ 1,046,633 Depreciation and Amortization expense for the three months ended March 31, 2022, was $16,458. Estimated future amortization expense as of March 31, 2022: March 31, 2022 2022 (Remaining 9 months) $ 48,663 2023 64,884 2024 64,884 2025 64,884 2026 64,884 Thereafter 738,434 Intangible assets, Net $ 1,046,633

Stockholder Equity

Stockholder Equity	3 Months Ended
	Mar. 31, 2022
Stockholder Equity
Stockholder Equity	Note 6 – Stockholder’ Equity The Company is authorized to issue 1,000,000 preferred stock shares and 200,000,000 common stock shares both with a par value of $0.0001. Preferred Stock On October 30, 2020, the Company designated 1,000,000 shares as Series D Convertible Preferred Stock with a par value of $0.0001. On April 16, 2021, the Company closed on a private placement of 440,125 shares of Series D Convertible Preferred Stock (the “Preferred Stock”) with a par value of $0.0001, yielding gross proceeds of $6,551,691 (the “Private Placement”) and settlement of a $50,000 liability for Preferred Stock shares. The Private Placement proceeds will be used for working capital, primarily for the development, manufacturing and commercialization of 374Water’s Air SCWO systems. The Preferred Stock has a stated value of $15 per share, is convertible into common stock at $0.30 per share and has voting rights based on the underlying shares of common stock. Upon liquidation of the Company, the Preferred Stockholders have a liquidation preference before any assets can be distributed to common stockholders. All of the Preferred Stock were sold pursuant to an exemption from registration requirements under Regulation D and/or Section 4(2) of the Securities Act of 1933, as amended. On September 29, 2021, 412,853 shares of Series D Preferred stock were converted into 20,642,667 shares of common stock. On January 12, 2022, the Company converted the remaining 27,272 shares of Series D Preferred stock to 1,363,149 shares of common stock. As of March 31, 2022, there were no shares of Series D Preferred stock issued and outstanding. Common Stock The holders of common stock are entitled to one vote per share on all matters submitted to a vote of shareholders, including the directors’ election. There is no right to cumulate votes in the election of directors. The holders of common stock are entitled to any dividends that may be declared by the board of directors out of funds legally available for payment of dividends subject to the prior rights of holders of preferred stock and any contractual restrictions the Company has against the payment of dividends on common stock. In the event of our liquidation or dissolution, holders of common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preferences of any outstanding shares of preferred stock. Holders of common stock have no preemptive rights and have no right to convert their common stock into any other securities. As of March 31, 2022, there were 126,680,895 shares of common stock issued and outstanding. Pursuant to the Merger, all Private 374Water shares were cancelled and the Company issued to the former Private 374Water stockholders a total of 62,410,452 shares of the Company’s common stock. On April 16, 2021, the Company issued a small block of shares of common stock estimated to have a fair value of $1,073,369 as consideration for the grant of a license to the Company (see Notes 5 and 8). During the three months ended March 31, 2022, the Company issued 1,363,149 shares of common stock from the conversion of 27,272 Preferred Stock shares. Stock-based compensation During the three months ended March 31, 2022, and 2021, the Company recorded stock-based compensation of $97,558 and $10,433, respectively, related to common stock issued or vested options to employees and various consultants of the Company. For the three months ended March 31, 2022, $93,868 was charged as general and administrative expenses and $3,690 as research and development expenses in the accompanying condensed consolidated statements of operations. For the three months ended March 31, 2021, $6,518 was charged as general and administrative expenses and $3,915 as research and development expenses in the accompanying condensed consolidated statements of operations. Stock Options Stock option activity for the three months ended March 31, 2022, is summarized as follows: Shares Weighted Average Exercise Price Aggregate Intrinsic Value Weighted Average Remaining Contractual Life (Years) Options outstanding at December 31, 2021 12,300,000 0.37 $ 4,521,310 5.62 Granted 360,000 3.33 — — Exercised — — — — Expired/forfeit — — — — Options outstanding at March 31, 2022 12,660,000 0.45 $ 5,719,310 5.39 Total unrecognized compensation associated with these unvested options is approximately $501,471 which will be recognized over a period of four years. The fair value of these options granted were estimated on the date of grant, using the Black-Scholes option-pricing model with the following assumptions: March 31, 2022 Dividend yield 0.00% Expected life 5.65 – 5.75 Years Expected volatility 37.73 – 39.18% Risk-free interest rate 1.44 – 2.12% Stock Warrants In April 2021, pursuant to the binding Memorandum of Understanding dated as of March 30, 2021, between 374Water and MB Holding Inc. (the “MOU”), a warrant for the purchase of 3,783,333 shares of common stock at an exercise price of $0.30 per share was issued to MB Holding Inc. as consideration for executing the MOU and was considered fully vested upon the execution of the MOU. These warrants were to expire in March 2022. Those warrants were estimated to have a grant-date fair value of $0.37 per warrant or aggregate fair value of $1,399,833 which has been presented as product development expense on the condensed statements of operations. During the year ended December 31, 2021, the warrants were exercised resulting in the issuance of 3,783,333 shares of common stock and proceeds of $1,134,499. Terry Merrell, a member of the Company’s Board of Directors, has sole voting and dispositive power over the securities held by MB Holdings Inc. As of March 31, 2022, there were 1,250,000 warrants outstanding which relate to the Series 1 offering executed in December 2021, where investors were offered a warrant for every two common shares purchased during the offering at an exercise price of $2.50 per share. The intrinsic value of all outstanding warrants as of March 31, 2022 was $437,500 based on the market price of our common stock of $2.85 per share. During the three months ended March 31, 2022, no warrants were issued or exercised. As of March 31, 2022, there are 1,250,000 outstanding warrants. A summary of warrant activity during the three months ended March 31, 2022, is as follows: Shares Weighted Average Exercise Price Aggregate Intrinsic Value Weighted Average Remaining Contractual Life (Years) Balance at December 31, 2021 1,250,000 2.50 $ 437,500 2.96 Issued — — —— — Exercised — — — — Balance at March 31, 2022 1,250,000 2.50 $ 437,500 2.72

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2022
Related Party Transactions
Related Party Transactions	Note 7 - Related Party Transactions In 2021, the Company entered into an agreement to fabricate and manufacture the AIRSCWO systems with Merrell Bros. Holding Company. As part of the agreement, the Company appointed Terry Merrell to its board of directors. As of March 31, 2022, Merrell Bros. or their affiliates own stock in excess of 5% of the outstanding common stock. As of March 31, 2022, the Company had $50,000 in related party expenses related to the manufacturing of the AIRSCWO systems.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies
Commitments And Contingencies	Note 8 – Commitments and Contingencies The patented technology underlying 374Water’s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (“Duke”), where Dr. Deshusses is a professor, is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the “License Agreement”). In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small block of common stock in the Company (See Notes 4 and 6). Under the terms of the License Agreement, the Company is required to make royalty payments based on a percentage of licensed product sales, as defined in the License Agreement which is triggered by the sale of licensed products. Further, the Company is also required to pay royalties on a percentage of sublicensing fees. The Company will reimburse Duke for any ongoing patent expenses incurred. During the three month period ending March 31, 2022, the Company has not incurred any expenses in connection with this License Agreement. The Company may terminate the license agreement anytime by providing Duke 60 days’ written notice.

Deferred Revenue

Deferred Revenue	3 Months Ended
	Mar. 31, 2022
Deferred Revenue
Deferred Revenue	Note 9 – Deferred Revenue As of March 31, 2022 and March 31, 2021, the Company had total deferred revenue of $763,333 and $0, respectively. As of March 31, 2022, the Company expects 100% of total deferred revenue to be realized in less than a year.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2022
Subsequent Events
Subsequents Events	Note 10 – Subsequent Events Effective April 13, 2022, in accordance with Section 228 of the Delaware Corporation Law, shareholders of the Company holding a majority of the voting power of the Company (the “Consenting Shareholders”) approved the adoption of the Company’s 2021 Equity Incentive Plan, reserving up to 10,000,000 shares of Common Stock for issuance in connection with awards thereunder (the “Equity Plan Adoption”).

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2022
Summary of Significant Accounting Policies
Cash And Cash Equivalents	The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company held no cash equivalents as of March 31, 2022, and December 31, 2021.
Accounts Receivable	Accounts receivables consist of balances due from service revenues. The Company monitors accounts receivable and provides allowances when considered necessary. At March 31, 2022 and December 31, 2021, there were no outstanding accounts receivable. Accordingly, no allowance for doubtful accounts was provided.
Equipment	Equipment is recorded at cost. Depreciation is computed using the straight-line method and an estimated useful live of three years. Expenses for maintenance and repairs are charged to expense as incurred. The Company’s depreciation expense in the period is $235.
Intangible Assets	Intangible assets are subject to amortization, and any impairment is determined in accordance with ASC 360, “Property, Plant, and Equipment.” Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined.
Long-lived Assets	The Company reviews long-lived assets, including intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. Recoverability of assets held and used is measured by a comparison of the carrying amount to the future undiscounted expected net cash flows to be generated by the asset. As of March 31, 2022, and 2021, there were no events or changes in circumstances requiring an impairment analysis.
Revenue Recognition And Concentration	The Company follows the revenue standards of Financial Accounting Standards Board Update No. 2014-09: “Revenue from Contracts with Customers (Topic 606).” The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation. Deferred revenue primarily consists of billings or payments received in advance of revenue recognition from the completion of the equipment build for each customer as the outputs are measured against the cost to build the product. The Company’s performance obligations will be satisfied overtime as the specialized equipment is built for the customer. Based on the Company’s contracts, the Company will have a single performance obligation (build and install of the product). The Company will primarily receive fixed consideration for sales of product. Revenues for the three months ended March 31, 2022 were generated from the sale of the first AIRSCWO system. For the three months ended March 31, 2021, the Company did not have any revenues.
Stock-based Compensation	The Company has accounted for stock-based compensation under the provisions of Accounting Standards Codification (ASC) Topic 718 – “Stock Compensation” which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.
Accounting For Uncertainty In Income Taxes	The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. There were no uncertain tax positions as of March 31, 2022, and December 31, 2021.
Income Tax Policy	The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.
Research And Development Costs	The Company’s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $185,653 and $29,185 for the three months ended March 31, 2022, and 2021, respectively.
Earnings (loss) Per Share	Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, “Earnings per Share”. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. As of March 31, 2022, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 12,660,000 shares of common stock. There were no dilutive shares as of March 31, 2022.
Financial Instruments	The Company carries cash, accounts receivable, accounts payable and accrued expenses, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values / useful lives of equipment and intangible assets due to their current nature.
Use Of Estimates	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, useful lives of intangible assets, and valuation allowance against deferred tax assets.
Recent Accounting Pronouncements	All other newly issued but not yet effective accounting pronouncements have been deemed to be not applicable or immaterial to the Company.

Acquisition of 374Water Inc f_2

Acquisition of 374Water Inc fka PowerVerde Inc (Tables)	3 Months Ended
	Mar. 31, 2022
Acquisition of 374Water Inc fka PowerVerde Inc
Schedule Of Assets And Liabilities Were Assumed	Cash $ 29,536 Prepaid expense 14,483 Accounts Receivable 1,000 Total assets acquired 45,019 Accounts payable (46,150 ) Accrued expenses (83,094 ) Total liabilities assumed $ (129,244 ) Net liabilities assumed $ (84,225 )

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2022
Intangible Assets
Schedule Of Intangible Assets	Name Estimated Life Balance at December 31, 2021 Additions Amortization Balance at March 31, 2022 License agreement 17 Years $ 1,028,114 $ — $ 15,787 $ 1,012,327 Patents 20 Years 34,742 — 436 34,306 Total $ 1,062,856 $ — $ 16,223 $ 1,046,633
Schedule Of Future Amortization Expense	March 31, 2022 2022 (Remaining 9 months) $ 48,663 2023 64,884 2024 64,884 2025 64,884 2026 64,884 Thereafter 738,434 Intangible assets, Net $ 1,046,633

Stockholder Equity (Tables)

Stockholder Equity (Tables)	3 Months Ended
	Mar. 31, 2022
Schedule Of Stock Option Activity	Shares Weighted Average Exercise Price Aggregate Intrinsic Value Weighted Average Remaining Contractual Life (Years) Options outstanding at December 31, 2021 12,300,000 0.37 $ 4,521,310 5.62 Granted 360,000 3.33 — — Exercised — — — — Expired/forfeit — — — — Options outstanding at March 31, 2022 12,660,000 0.45 $ 5,719,310 5.39
Schedule Of Warrant Activity	Shares Weighted Average Exercise Price Aggregate Intrinsic Value Weighted Average Remaining Contractual Life (Years) Balance at December 31, 2021 1,250,000 2.50 $ 437,500 2.96 Issued — — —— — Exercised — — — — Balance at March 31, 2022 1,250,000 2.50 $ 437,500 2.72
Stock Option [Member]
Schedule Of Stock Option Assumptions	March 31, 2022 Dividend yield 0.00% Expected life 5.65 – 5.75 Years Expected volatility 37.73 – 39.18% Risk-free interest rate 1.44 – 2.12%

Nature of Business and Presen_2

Nature of Business and Presentation of Financial Statements (Details Narrative)	1 Months Ended
	Apr. 16, 2021shares
Nature of Business and Presentation of Financial Statements
Shares Issued To Former Holder	62,410,452
Merger Effect Description	Immediately following the Merger, Private 374Water changed its name to 374Water Systems Inc and PowerVerde changed its name to 374Water, Inc. After the Merger, the former Private 374Water stockholders own 64.2% of the Company’s issued and outstanding common stock and 53.8% of the Company’s issued and outstanding voting stock which includes the Preferred Stock.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Summary of Significant Accounting Policies (Details Narrative)
Depreciation	$ 235
Research And Development Cost	$ 185,653	$ 29,185
Antidilutive Excluded From Computation Of Earnings Per Share, Shares	12,660,000

Liquidity Capital Resources a_2

Liquidity Capital Resources and Going Concern (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Nature of Business and Presentation of Financial Statements
Accumulated Deficit	$ 4,032,873		$ 3,160,015
Net Income (loss)	(872,858)	$ (66,551)
Net Cash Used In Operations	115,911
Working Capital	$ 10,501,137		$ 11,263,270

Acquisition of 374Water Inc f_3

Acquisition of 374Water Inc fka PowerVerde Inc (Details) - 374Water, Inc. [Member]	Dec. 31, 2021USD ($)
Cash	$ 29,536
Prepaid Expense	14,483
Accounts Receivable	1,000
Total Assets Acquired	45,019
Accounts Payable	46,150
Accrued Expenses	(83,094)
Total Liabilities Assumed	129,244
Net Liabilities Assumed	$ (84,225)

Acquisition of 374Water Inc f_4

Acquisition of 374Water Inc fka PowerVerde Inc (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended
	Apr. 16, 2021	Mar. 31, 2022	Dec. 31, 2021
Preferred Stock, Par Value		$ 0.0001	$ 0.0001
Series D Preferred Stock [Member]
Description Issuance Of The Preferred Stock		the former Private 374Water shareholders own 65.8% of the Company’s issued and outstanding common stock and 53.8% of the Company’s issued and outstanding voting stock
Preferred Stock, Par Value		$ 0.0001
Gross Proceeds From Private Placement	$ 6,551,691	$ 6,551,745
Shares In Private Placement		436,783
Settlement Of Liability For Preferred Stock Shares		$ 50,000
Mr Nagar
Annual Salary		200,000
Annaul Salary Increased Amount		250,000
CEO [Member]
Annual Salary		$ 60,000

Intangible Assets (Details)

Intangible Assets (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Intangible Assets Additions	$ 0
Accumulated Amortization	16,223
Net Book Value	1,046,633
Intangible Assets Gross		$ 1,062,856
License Agreement [Member]
Intangible Assets Additions	0
Accumulated Amortization	15,787
Net Book Value	$ 1,012,327
Intangible Assets Gross		1,028,114
Estimated Life	17 years
Patents [Member]
Intangible Assets Additions	$ 0
Accumulated Amortization	436
Net Book Value	$ 34,306
Intangible Assets Gross		$ 34,742
Estimated Life	20 years

Intangible Assets (Details 1)

Intangible Assets (Details 1)	Mar. 31, 2022USD ($)
Intangible Assets
2022 (remaining 9 Months)	$ 48,663
2023	64,884
2024	64,884
2025	64,884
2026	64,884
Thereafter	738,434
Intangible Assets, Net	$ 1,046,633

Intangible Assets (Details Narr

Intangible Assets (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Amortization Of Intangible Assets	$ 16,458
Common Shares Issued, Fair Value	12,669	$ 12,531
License Agreement [Member]
Common Shares Issued, Fair Value	$ 1,073,529

Stockholder Equity (Details)

Stockholder Equity (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Granted	0
Weighted Average Exercise Price ,beginning	$ 2.50
Weighted Average Exercise Price ,ending		$ 2.50
Aggregate Intrinsic Value ,ending	$ 437,500	$ 437,500
Aggregate Intrinsic Value, Beginng	$ 437,500
Weighted Average Remaining Contractual Life(years)	2 years 8 months 19 days	2 years 11 months 15 days
Options [Member]
Options Outstanding ,beginning Balance	12,300,000
Granted	360,000
Exercised	0
Expired/forfeited	0
Options Outstanding ,ending Balance	12,660,000	12,300,000
Weighted Average Exercise Price ,beginning	$ 0.37
Weighted Average Exercise Price, Granted	3.33
Weighted Average Exercise Price, Exercised	0
Weighted Average Exercise Price, Expired/forfeit	0
Weighted Average Exercise Price ,ending	$ 0.45	$ 0.37
Aggregate Intrinsic Value ,ending	$ 5,719,310	$ 4,521,310
Aggregate Intrinsic Value, Beginng	$ 4,521,310
Weighted Average Remaining Contractual Life(years)	5 years 4 months 20 days	5 years 7 months 13 days

Stockholder Equity (Details 1)

Stockholder Equity (Details 1) - Options [Member]	3 Months Ended
	Mar. 31, 2022
Dividend Yield	0.00%
Minimum [Member]
Expected Life	5 years 7 months 24 days
Expected Volatility	37.73%
Risk-free Interest Rate	1.44%
Maximum [Member]
Expected Life	5 years 9 months
Expected Volatility	39.18%
Risk-free Interest Rate	2.12%

Stockholder Equity (Details 2)

Stockholder Equity (Details 2) - USD ($)	1 Months Ended	3 Months Ended	12 Months Ended
	Apr. 30, 2021	Mar. 31, 2022	Dec. 31, 2021
Stockholder Equity
Balance At Beginning		1,250,000
Shares Issued		0
Shares Exercised		0
Balance At End		1,250,000	1,250,000
Aggregate Intrinsic Value, Beginng		$ 437,500
Aggregate Intrinsic Value ,ending		$ 437,500	$ 437,500
Weighted Average Remaining Contractual Life(years)		2 years 8 months 19 days	2 years 11 months 15 days
Weighted Average Exercise Price ,beginning		$ 2.50
Weighted Average Exercise Price Issued	$ 0.37	0
Weighted Average Exercise Price Exercised		0
Weighted Average Exercise Price Balance At Ending		$ 2.50

Stockholder Equity (Details Nar

Stockholder Equity (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended
	Apr. 30, 2021	Apr. 16, 2021	Mar. 31, 2022	Mar. 31, 2021	Jan. 12, 2022	Dec. 31, 2021	Sep. 29, 2021	Oct. 30, 2020
Stock Issued Upon Warrant Exercised						3,783,333
Proceeds From Stock Issued Upon Warrants Exercised						$ 1,134,499
Warrants Outstanding Series 1			1,250,000
Intrinsic Value Of Warrants			$ 437,500			$ 437,500
Common Stock Issued On Conversion			1,363,149
Preferred Stock Converted			27,272
Preferred Stock Shares Authorized			1,000,000			1,000,000
Common Stock Shares Authorized			200,000,000			200,000,000
Preferred Stock, Shares Issued		440,125	0			27,272
Liability For Preferred Stock Shares			$ 50,000
Number Of Warrant Purchase	3,783,333
Exercise Price	$ 0.30
Weighted Average Exercise Price Issued	$ 0.37		$ 0
Aggregate Fair Value Of Warrant	$ 1,399,833
Warrants Outstanding			1,250,000			1,250,000
Common Stock Price			$ 2.85
Weighted Average Exercise Price			2.50
Preferred Stock, Par Value			0.0001			$ 0.0001
Common Stock Value Per Share			$ 0.0001			$ 0.0001
Common Stock, Shares Outstanding			126,680,895			125,317,746
Common Stock, Shares Issued			126,680,895			125,317,746
Common Shares Issued, Fair Value			$ 12,669			$ 12,531
Stock-based Compensation			97,558	$ 10,433
Research And Development			185,653	29,185
General And Administrative			261,403	10,477
Options [Member]
Intrinsic Value Of Warrants			5,719,310			$ 4,521,310
Unrecognized Compensation Expense, Unvested Options			501,471
374Water, Inc. [Member]
Common Stock Value Per Share		$ 0.30
Preferred Stock Stated Value Per Share		$ 15
Consultant [Member]
Stock-based Compensation			97,558	10,433
Research And Development			3,690	3,915
General And Administrative			$ 93,868	$ 6,518
Patents [Member]
Common Shares Issued, Fair Value		$ 1,073,369
374Water Former Stockholders [Member]
Common Stock, Shares Issued		62,410,452
Series D Preferred Stock [Member]
Preferred Stock Shares Authorized					27,272		412,853	1,000,000
Preferred Stock, Par Value			$ 0.0001
Gross Process From Private Placement Of Stocks		$ 6,551,691	$ 6,551,745
Preferred Stock Value Per Share								$ 0.0001
Convertion Of Preferred Stock To Common Stock					1,363,149		20,642,667

Related Party Transactions (Det

Related Party Transactions (Details Narrative)	3 Months Ended
	Mar. 31, 2022USD ($)
Related Party Transactions
Related Party Cost	$ 50,000
Stock In Excess Percentage Of Outstanding Share	5.00%

Deferred Revenue (Details Narra

Deferred Revenue (Details Narrative) - USD ($)	Mar. 31, 2022	Mar. 31, 2021
Deferred Revenue
Deferred Revenue	$ 763,333	$ 0
Deferred Revenue Percentage	100.00%

Subsequent Events (Details Narr

Subsequent Events (Details Narrative)	Apr. 13, 2022shares
Subsequent Event [Member]
Shares Of Common Stock Reserve For Issuance	10,000,000